401k Plan data: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST plan

IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 401k Plan overview

Plan Name	IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST
Plan identification number	001

IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

IRIX PHARMACEUTICALS, INC has sponsored the creation of one or more 401k plans.

Company Name: IRIX PHARMACEUTICALS, INC

Employer identification number (EIN): 571045477

NAIC Classification: 325410

Form 5500 Filing Information

Submission information for form 5500 for 401k plan IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2015-01-01 LISA MULLEN
001 2014-01-01 LISA MULLEN
001 2014-01-01
001 2014-01-01 LISA MULLEN
001 2013-01-01
001 2012-01-01 MICHAEL J. BOSSE MICHAEL J. BOSSE 2013-10-15
001 2011-01-01 MICHAEL J. BOSSE
001 2010-01-01 MICHAEL BOSSE
001 2009-01-01 MICHAEL BOSSE
001 2009-01-01 MICHAEL J. BOSSE MICHAEL J. BOSSE 2010-10-15

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
001	2015-01-01	LISA MULLEN
001	2014-01-01	LISA MULLEN
001	2014-01-01
001	2014-01-01	LISA MULLEN
001	2013-01-01
001	2012-01-01	MICHAEL J. BOSSE	MICHAEL J. BOSSE	2013-10-15
001	2011-01-01	MICHAEL J. BOSSE
001	2010-01-01	MICHAEL BOSSE
001	2009-01-01	MICHAEL BOSSE
001	2009-01-01	MICHAEL J. BOSSE	MICHAEL J. BOSSE	2010-10-15

Plan Statistics for IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST

401k plan membership statisitcs for IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST

Measure Date Value
2015: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2015 401k membership
Total participants, beginning-of-year 2015-01-01 265
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 0
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 0
Total of all active and inactive participants 2015-01-01 0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 0
Number of participants with account balances 2015-01-01 0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2014 401k membership
Total participants, beginning-of-year 2014-01-01 247
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 171
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 94
Total of all active and inactive participants 2014-01-01 265
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 265
Number of participants with account balances 2014-01-01 187
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0
2013: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2013 401k membership
Total participants, beginning-of-year 2013-01-01 228
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 153
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 93
Total of all active and inactive participants 2013-01-01 246
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 246
Number of participants with account balances 2013-01-01 177
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 0
2012: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2012 401k membership
Total participants, beginning-of-year 2012-01-01 214
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 127
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 101
Total of all active and inactive participants 2012-01-01 228
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 228
Number of participants with account balances 2012-01-01 181
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 0
2011: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2011 401k membership
Total participants, beginning-of-year 2011-01-01 203
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 123
Number of retired or separated participants receiving benefits 2011-01-01 0
Number of other retired or separated participants entitled to future benefits 2011-01-01 91
Total of all active and inactive participants 2011-01-01 214
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 0
Total participants 2011-01-01 214
Number of participants with account balances 2011-01-01 192
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 0
2010: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2010 401k membership
Total participants, beginning-of-year 2010-01-01 212
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 126
Number of retired or separated participants receiving benefits 2010-01-01 0
Number of other retired or separated participants entitled to future benefits 2010-01-01 77
Total of all active and inactive participants 2010-01-01 203
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 0
Total participants 2010-01-01 203
Number of participants with account balances 2010-01-01 174
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 0
2009: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2009 401k membership
Total participants, beginning-of-year 2009-01-01 177
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 134
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 78
Total of all active and inactive participants 2009-01-01 212
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 212
Number of participants with account balances 2009-01-01 182
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 0

Measure	Date	Value
2015: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2015 401k membership
Total participants, beginning-of-year	2015-01-01	265
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	0
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	0
Total of all active and inactive participants	2015-01-01	0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	0
Number of participants with account balances	2015-01-01	0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2014 401k membership
Total participants, beginning-of-year	2014-01-01	247
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	171
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	94
Total of all active and inactive participants	2014-01-01	265
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	265
Number of participants with account balances	2014-01-01	187
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0
2013: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2013 401k membership
Total participants, beginning-of-year	2013-01-01	228
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	153
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	93
Total of all active and inactive participants	2013-01-01	246
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	246
Number of participants with account balances	2013-01-01	177
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	0
2012: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2012 401k membership
Total participants, beginning-of-year	2012-01-01	214
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	127
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	101
Total of all active and inactive participants	2012-01-01	228
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	228
Number of participants with account balances	2012-01-01	181
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	0
2011: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2011 401k membership
Total participants, beginning-of-year	2011-01-01	203
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	123
Number of retired or separated participants receiving benefits	2011-01-01	0
Number of other retired or separated participants entitled to future benefits	2011-01-01	91
Total of all active and inactive participants	2011-01-01	214
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	0
Total participants	2011-01-01	214
Number of participants with account balances	2011-01-01	192
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	0
2010: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2010 401k membership
Total participants, beginning-of-year	2010-01-01	212
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	126
Number of retired or separated participants receiving benefits	2010-01-01	0
Number of other retired or separated participants entitled to future benefits	2010-01-01	77
Total of all active and inactive participants	2010-01-01	203
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	0
Total participants	2010-01-01	203
Number of participants with account balances	2010-01-01	174
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	0
2009: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2009 401k membership
Total participants, beginning-of-year	2009-01-01	177
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	134
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	78
Total of all active and inactive participants	2009-01-01	212
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	212
Number of participants with account balances	2009-01-01	182
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	0

Financial Data on IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST

Measure	Date	Value
2015 : IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-29	$0
Total transfer of assets from this plan	2015-12-29	$5,595,751
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-29	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-29	$0
Total income from all sources (including contributions)	2015-12-29	$483,083
Total loss/gain on sale of assets	2015-12-29	$0
Total of all expenses incurred	2015-12-29	$230,655
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-29	$228,845
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-29	$472,797
Value of total assets at end of year	2015-12-29	$0
Value of total assets at beginning of year	2015-12-29	$5,343,323
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-29	$1,810
Total interest from all sources	2015-12-29	$-2,403
Total dividends received (eg from common stock, registered investment company shares)	2015-12-29	$41,659
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-29	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2015-12-29	$0
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-29	$41,659
Was this plan covered by a fidelity bond	2015-12-29	Yes
Value of fidelity bond cover	2015-12-29	$500,000
If this is an individual account plan, was there a blackout period	2015-12-29	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-29	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-29	No
Contributions received from participants	2015-12-29	$472,797
Participant contributions at end of year	2015-12-29	$0
Participant contributions at beginning of year	2015-12-29	$85,230
Participant contributions at end of year	2015-12-29	$0
Participant contributions at beginning of year	2015-12-29	$29,815
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-29	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-29	No
Value of net income/loss	2015-12-29	$252,428
Value of net assets at end of year (total assets less liabilities)	2015-12-29	$0
Value of net assets at beginning of year (total assets less liabilities)	2015-12-29	$5,343,323
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-29	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-29	No
Were any leases to which the plan was party in default or uncollectible	2015-12-29	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-29	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-29	$5,228,278
Interest on participant loans	2015-12-29	$-2,403
Income. Interest from loans (other than to participants)	2015-12-29	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2015-12-29	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-29	$-28,970
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-29	No
Was there a failure to transmit to the plan any participant contributions	2015-12-29	No
Has the plan failed to provide any benefit when due under the plan	2015-12-29	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-29	$228,845
Contract administrator fees	2015-12-29	$1,810
Did the plan have assets held for investment	2015-12-29	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-29	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-29	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-29	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-29	Disclaimer
Accountancy firm name	2015-12-29	WEBSTER ROGERS, LLP
Accountancy firm EIN	2015-12-29	570776381
2014 : IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$7,717
Total income from all sources (including contributions)	2014-12-31	$881,249
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$384,771
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$384,231
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$594,885
Value of total assets at end of year	2014-12-31	$5,343,321
Value of total assets at beginning of year	2014-12-31	$4,854,560
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$540
Total interest from all sources	2014-12-31	$116,810
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$40,202
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2014-12-31	$0
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$40,202
Administrative expenses professional fees incurred	2014-12-31	$300
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$373,151
Participant contributions at end of year	2014-12-31	$85,229
Participant contributions at beginning of year	2014-12-31	$98,118
Participant contributions at end of year	2014-12-31	$29,815
Participant contributions at beginning of year	2014-12-31	$23,354
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$221,734
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2014-12-31	$7,717
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$496,478
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$5,343,321
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$4,846,843
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$4,378,892
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$3,930,284
Interest on participant loans	2014-12-31	$7,899
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2014-12-31	$849,385
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2014-12-31	$802,804
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2014-12-31	$802,804
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2014-12-31	$108,911
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$129,352
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$384,231
Contract administrator fees	2014-12-31	$540
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	WEBSTER ROGERS, LLP
Accountancy firm EIN	2014-12-31	570776381
2013 : IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2013 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$7,717
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$29,064
Total income from all sources (including contributions)	2013-12-31	$1,083,736
Total of all expenses incurred	2013-12-31	$185,682
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$184,317
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$287,225
Value of total assets at end of year	2013-12-31	$4,854,560
Value of total assets at beginning of year	2013-12-31	$3,977,853
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$1,365
Total interest from all sources	2013-12-31	$8,171
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$30,765
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$30,765
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$500,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$287,225
Participant contributions at end of year	2013-12-31	$98,118
Participant contributions at beginning of year	2013-12-31	$74,278
Participant contributions at end of year	2013-12-31	$23,354
Participant contributions at beginning of year	2013-12-31	$22,961
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$898,054
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$4,846,843
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$3,948,789
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$3,930,284
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$3,176,793
Interest on participant loans	2013-12-31	$8,171
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2013-12-31	$802,804
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2013-12-31	$703,821
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2013-12-31	$703,821
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$757,575
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$184,317
Contract administrator fees	2013-12-31	$1,365
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Liabilities. Value of acquisition indebtedness at end of year	2013-12-31	$7,717
Liabilities. Value of acquisition indebtedness at beginning of year	2013-12-31	$29,064
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	WEBSTERROGERS LLP
Accountancy firm EIN	2013-12-31	570776381
2012 : IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2012 401k financial data
Total unrealized appreciation/depreciation of assets	2012-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$29,064
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$39,366
Total income from all sources (including contributions)	2012-12-31	$700,439
Total loss/gain on sale of assets	2012-12-31	$0
Total of all expenses incurred	2012-12-31	$341,062
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$339,247
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$273,373
Value of total assets at end of year	2012-12-31	$3,977,853
Value of total assets at beginning of year	2012-12-31	$3,628,778
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$1,815
Total interest from all sources	2012-12-31	$6,633
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$37,389
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$37,389
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$500,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$273,373
Participant contributions at end of year	2012-12-31	$74,278
Participant contributions at beginning of year	2012-12-31	$69,656
Participant contributions at end of year	2012-12-31	$22,961
Participant contributions at beginning of year	2012-12-31	$19,703
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2012-12-31	$29,064
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2012-12-31	$39,366
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$359,377
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$3,948,789
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$3,589,412
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$3,176,793
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$2,770,019
Interest on participant loans	2012-12-31	$6,633
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2012-12-31	$703,821
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2012-12-31	$769,400
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2012-12-31	$769,400
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$383,044
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$339,247
Contract administrator fees	2012-12-31	$1,815
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	WEBSTER ROGERS, LLP
Accountancy firm EIN	2012-12-31	570776381
2011 : IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2011 401k financial data
Total unrealized appreciation/depreciation of assets	2011-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$39,366
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$116,945
Total income from all sources (including contributions)	2011-12-31	$196,610
Total loss/gain on sale of assets	2011-12-31	$0
Total of all expenses incurred	2011-12-31	$143,469
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$141,789
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$286,902
Value of total assets at end of year	2011-12-31	$3,628,778
Value of total assets at beginning of year	2011-12-31	$3,653,216
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$1,680
Total interest from all sources	2011-12-31	$6,418
Total dividends received (eg from common stock, registered investment company shares)	2011-12-31	$32,913
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2011-12-31	$32,913
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$500,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$286,902
Participant contributions at end of year	2011-12-31	$69,656
Participant contributions at beginning of year	2011-12-31	$81,048
Participant contributions at end of year	2011-12-31	$19,703
Participant contributions at beginning of year	2011-12-31	$25,738
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2011-12-31	$39,366
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2011-12-31	$116,945
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$53,141
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$3,589,412
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$3,536,271
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$2,770,019
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$2,689,415
Interest on participant loans	2011-12-31	$6,418
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2011-12-31	$769,400
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2011-12-31	$757,538
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2011-12-31	$757,538
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-129,623
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Employer contributions (assets) at beginning of year	2011-12-31	$99,477
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$141,789
Contract administrator fees	2011-12-31	$1,680
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	WEBSTERROGERS LLP
Accountancy firm EIN	2011-12-31	570776381
2010 : IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2010 401k financial data
Total unrealized appreciation/depreciation of assets	2010-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$116,945
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$83,498
Total income from all sources (including contributions)	2010-12-31	$662,762
Total loss/gain on sale of assets	2010-12-31	$0
Total of all expenses incurred	2010-12-31	$176,073
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$174,848
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$392,257
Value of total assets at end of year	2010-12-31	$3,653,216
Value of total assets at beginning of year	2010-12-31	$3,133,080
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$1,225
Total interest from all sources	2010-12-31	$10,017
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$30,854
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2010-12-31	$30,854
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$500,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$309,525
Participant contributions at end of year	2010-12-31	$81,048
Participant contributions at beginning of year	2010-12-31	$100,474
Participant contributions at end of year	2010-12-31	$25,738
Participant contributions at beginning of year	2010-12-31	$26,234
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$82,732
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2010-12-31	$116,945
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2010-12-31	$83,498
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$486,689
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$3,536,271
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$3,049,582
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$2,689,415
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$2,268,014
Interest on participant loans	2010-12-31	$10,007
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2010-12-31	$757,538
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2010-12-31	$638,881
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2010-12-31	$638,881
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2010-12-31	$10
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$229,634
Net investment gain or loss from common/collective trusts	2010-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Employer contributions (assets) at end of year	2010-12-31	$99,477
Employer contributions (assets) at beginning of year	2010-12-31	$99,477
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$174,848
Contract administrator fees	2010-12-31	$1,225
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	WEBSTERROGERS LLP
Accountancy firm EIN	2010-12-31	570776381
2009 : IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST

2015: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	Yes
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2010: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2010 form 5500 responses
2010-01-01	Type of plan entity	Single employer plan
2010-01-01	Submission has been amended	No
2010-01-01	This submission is the final filing	No
2010-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2010-01-01	Plan is a collectively bargained plan	No
2010-01-01	Plan funding arrangement – Trust	Yes
2010-01-01	Plan benefit arrangement - Trust	Yes
2009: IRIX PHARMACEUTICALS, INC 401(K) PLAN AND TRUST 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	Yes
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	IRIX PHARMACEUTICALS, INC
Employer identification number (EIN):	571045477
NAIC Classification:	325410